Loading...
OTCM
TLCC
Market cap155kUSD
Nov 03, Last price  
0.00USD
Name

Twinlab Consolidated Holdings Inc

Chart & Performance

D1W1MN
OTCM:TLCC chart
P/E
P/S
0.01
EPS
Div Yield, %
Shrs. gr., 5y
-0.58%
Rev. gr., 5y
-28.58%
Revenues
14m
-20.87%
84,236,00076,230,00061,426,00081,672,00086,323,00085,501,00073,291,00073,460,00066,349,00072,089,00017,208,00013,617,000
Net income
-14m
L+66.80%
-2,881,000-2,482,000-21,130,000-36,410,000-684,000-29,491,000-20,409,000-44,501,000-14,389,000-14,940,000-8,222,000-13,714,000
CFO
3m
P
-5,987,0003,897,000-14,735,000-1,959,000-25,330,000-6,503,000-6,564,000-8,411,000-5,070,0002,650,000-4,311,0002,897,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Twinlab Consolidated Holdings, Inc., along with its subsidiaries, operates as a global producer, marketer, and retailer of nutritional supplements and natural health products. Its extensive portfolio features a variety of offerings under several well-known brands. Under the flagship Twinlab brand, it includes vitamins, minerals, specialty supplements such as resveratrol, collagen, and keratin, as well as sports nutrition items. Healthy aging and beauty solutions are available through the Reserveage Nutrition and ResVitale labels. Metabolife provides diet and energy products, while Alvita offers a selection of herbal teas. Beyond its proprietary brands, the company also offers contract manufacturing services for private label clients. Products are supplied in numerous formats, including capsules, tablets, softgels, chewables, liquids, stick packs, sprays, and powders, catering to diverse consumer preferences. Distribution channels primarily encompass health and natural food stores, supermarkets, large-scale retailers, specialized outlets, online platforms, and the company's own e-commerce sites. Founded in 2013, Twinlab Consolidated Holdings, Inc. maintains its corporate headquarters in Boca Raton, Florida.
IPO date
Jun 25, 2014
Employees
46
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT